 Thyrotropin-Releasing Hormone
"Thyrotropin-Releasing Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tripeptide that stimulates the release of THYROTROPIN and PROLACTIN. It is synthesized by the neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, TRH (was called TRF) stimulates the release of TSH and PRL from the ANTERIOR PITUITARY GLAND.
| Descriptor ID |
D013973
|
| MeSH Number(s) |
D06.472.699.327.740.880 D12.644.400.400.740.880 D12.644.456.837 D12.644.548.365.740.880 D12.776.641.650.405.740.880 D12.776.641.650.810
|
| Concept/Terms |
Thyrotropin-Releasing Hormone- Thyrotropin-Releasing Hormone
- Thyrotropin Releasing Hormone
- Thyrotropin-Releasing Factor
- Thyrotropin Releasing Factor
- Protirelin
Antepan- Antepan
- Henning Berlin Brand of Protirelin
Protirelin Tartrate (1:1)- Protirelin Tartrate (1:1)
- Thyrotropin-Releasing Hormone Tartrate
- Thyrotropin Releasing Hormone Tartrate
- Proterelin Tartrate
TRH Prem- TRH Prem
- Prem, TRH
- Novartis Brand of Protirelin
- Protirelin Novartis Brand
Stimu-TSH- Stimu-TSH
- Stimu TSH
- StimuTSH
- TRH Ferring
- Ferring Brand of Protirelin
- Protirelin Ferring Brand
Thypinone- Thypinone
- Abbott Brand of Protirelin
- Protirelin Abbott Brand
Thyroliberin- Thyroliberin
- Thyroliberin TRH Merck
- Merck Brand of Protirelin
- Protirelin Merck Brand
Relefact TRH- Relefact TRH
- TRH, Relefact
- Aventis Brand of Protirelin
- Protirelin Aventis Brand
|
Below are MeSH descriptors whose meaning is more general than "Thyrotropin-Releasing Hormone".
Below are MeSH descriptors whose meaning is more specific than "Thyrotropin-Releasing Hormone".
This graph shows the total number of publications written about "Thyrotropin-Releasing Hormone" by people in this website by year, and whether "Thyrotropin-Releasing Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 1 | 2 | | 1983 | 0 | 1 | 1 | | 1984 | 1 | 0 | 1 | | 1985 | 0 | 1 | 1 | | 1987 | 1 | 0 | 1 | | 1990 | 1 | 1 | 2 | | 1991 | 0 | 2 | 2 | | 1993 | 0 | 1 | 1 | | 1999 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 2 | 4 | | 2007 | 0 | 3 | 3 | | 2008 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Thyrotropin-Releasing Hormone" by people in Profiles.
-
Turgeon MO, Silander TL, Doycheva D, Liao XH, Rigden M, Ongaro L, Zhou X, Joustra SD, Wit JM, Wade MG, Heuer H, Refetoff S, Bernard DJ. TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice. Endocrinology. 2017 04 01; 158(4):815-830.
-
Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015 Oct; 3(10):816-25.
-
Ikegami K, Liao XH, Hoshino Y, Ono H, Ota W, Ito Y, Nishiwaki-Ohkawa T, Sato C, Kitajima K, Iigo M, Shigeyoshi Y, Yamada M, Murata Y, Refetoff S, Yoshimura T. Tissue-specific posttranslational modification allows functional targeting of thyrotropin. Cell Rep. 2014 Nov 06; 9(3):801-10.
-
Fonseca TL, Correa-Medina M, Campos MP, Wittmann G, Werneck-de-Castro JP, Arrojo e Drigo R, Mora-Garzon M, Ueta CB, Caicedo A, Fekete C, Gereben B, Lechan RM, Bianco AC. Coordination of hypothalamic and pituitary T3 production regulates TSH expression. J Clin Invest. 2013 Apr; 123(4):1492-500.
-
Shukla PK, Sittig LJ, Andrus BM, Schaffer DJ, Batra KK, Redei EE. Prenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels. Psychoneuroendocrinology. 2010 Jul; 35(6):791-7.
-
Sánchez E, Singru PS, Acharya R, Bodria M, Fekete C, Zavacki AM, Bianco AC, Lechan RM. Differential effects of refeeding on melanocortin-responsive neurons in the hypothalamic paraventricular nucleus. Endocrinology. 2008 Sep; 149(9):4329-35.
-
Adams BA, Gray SL, Isaac ER, Bianco AC, Vidal-Puig AJ, Sherwood NM. Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology. 2008 Apr; 149(4):1571-80.
-
Hernandez A, Martinez ME, Liao XH, Van Sande J, Refetoff S, Galton VA, St Germain DL. Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology. 2007 Dec; 148(12):5680-7.
-
Olivares EL, Marassi MP, Fortunato RS, da Silva AC, Costa-e-Sousa RH, Araújo IG, Mattos EC, Masuda MO, Mulcahey MA, Huang SA, Bianco AC, Carvalho DP. Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology. 2007 Oct; 148(10):4786-92.
-
Nikrodhanond AA, Ortiga-Carvalho TM, Shibusawa N, Hashimoto K, Liao XH, Refetoff S, Yamada M, Mori M, Wondisford FE. Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem. 2006 Feb 24; 281(8):5000-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|